Navigation Links
Video and Photo: Tasigna(R) Receives US Approval Providing New Hope to Chronic Myeloid Leukemia Patients With Resistance or Intolerance to Existing Therapies
Date:10/29/2007

ure should be monitored carefully, and any patient with signs or symptoms consistent with cardiac failure should be evaluated and treated.

Dose adjustments may be necessary due to hepatotoxicity, other nonhematologic adverse reactions, or hematologic adverse reactions. Therapy with Gleevec was discontinued for drug-related adverse reactions in 2.4% to 5% of patients.

A 25% decrease in the recommended dose should be used for patients with severe hepatic impairment.

Patients should be weighed and monitored regularly for signs and symptoms of edema, which can be serious or life-threatening. There have also been reports, including fatalities, of cardiac tamponade, cerebral edema, increased intracranial pressure, papilledema, and gastrointestinal (GI) perforation.

Bullous dermatologic reactions (eg, erythema multiforme and Stevens- Johnson syndrome) have also been reported. In some cases, the reaction recurred upon rechallenge. Several postmarketing reports describe patients able to tolerate the reintroduction of Gleevec at a lower dose with or without concomitant corticosteroids or antihistamines following resolution or improvement of the bullous reaction.

Consider potential toxicities-specifically liver, kidney, and cardiac toxicity, and immunosuppression from long-term use.

Gleevec is metabolized by the CYP3A4 isoenzyme and is an inhibitor of CYP3A4, CYP2D6, and CYP2C9. Dosage of Gleevec should increase by at least 50%, and clinical response should be carefully monitored, in patients receiving Gleevec with a potent CYP3A4 inducer such as rifampin or phenytoin. Examples of commonly used drugs that may significantly interact with Gleevec include ketoconazole, acetaminophen, warfarin, erythromycin, and phenytoin. (Please see full Prescribing Information for other potential drug interactions).

For daily dosing of 800 mg and above, dosing should be accomplished using the 400 mg tablet to reduce exposure to iron.

Common side e
'/>"/>

SOURCE Novartis
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Cut down TV and video games and you have less aggressive children.
2. Parents Should Beware of Violent Video Games
3. Children’s obesity linked to video game
4. Poland: Parental warning systems are likely to be adopted in video games.
5. Video Games, The Latest Craze Of American Adults
6. Interactive Video, Better Teaching Aid For Toddlers
7. Video Games Reduces Surgical Errors – A Stud
8. Fun And Cure With Video Games
9. Stroke Rehabilitation Through Modified Video Games
10. Videoconferencing, an impetus to Pediatric Oncology
11. Free Online Educational Videos for People with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... Americans live closer to their dogs ... Veterinary Medical Association (AVMA) U.S. Pet Ownership and Demographics ... their dog a member of the family, up from ... five years earlier. , According to the American Pet ... income dedicated to pets has increased every year without ...
(Date:5/19/2013)... 2013 The Fat Loss Code program developed ... that help people get in shape, and gain a ... The program also is a natural fat loss system that ... author of this fat loss diet program claimed that The ... help people keep body fat off long-term. After Shawn Stevenson ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Agora Health Limited ... that covers guides on how to increase memory power ... memory training method that helps people re-new their entire health ... and beat depression caused by a fatigued mind. In addition, ... razor sharp for a lifetime. The author claimed that this ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 Beginning Wednesday, May ... Valley Blood Center (RRVBC) will feature “Hot Dog Wednesdays" and ... RRVBC will provide hot dogs and all the fixin's ... slushies each day throughout the summer. “Donors are our lifeline. ... a stable and adequate blood supply. This is a ...
(Date:5/19/2013)... Florida (PRWEB) May 19, 2013 ... market access, is pleased to unveil a new and ... environment that provides a powerful array of real-time communication ... in the US and abroad. , HE-Xpo is powered ... offer attendees the look and feel of being at ...
Breaking Medicine News(10 mins):Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 2Health News:Dogs Becoming Part of the Family: Dog Bite Injuries Decreasing 3Health News:Weight Loss Secrets | How “The Fat Loss Code” Helps People Gain A Healthy Life And Get In Shape - Health Review 2Health News:How To Increase Memory Power | How “Agora Health Limited” Helps People Improve Their Memory Naturally And Effectively – Health Review 2Health News:Hot Dog Wednesdays and Ice Cold Slushies Return to Rock River Valley Blood Center for the Summer 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 2Health News:HealthEconomics.Com Announces HE-Xpo, a New Virtual Trade Show Devoted to Healthcare Value and Market Access 3
... Japan, March 30 ... reorganization of its corporate structure, as part of ... global pharmaceutical company with highly integrated global operations. ... changes in the global operating environment and to ...
... The American Association of Oral and Maxillofacial ... Oral Health Rehabilitative Enhancement Act of 2009" (H.R. 1430 IH), ... referring their Medicare patients for physical therapy. Introduced on March ... (D-N.J.) and Congressman Eric Cantor (R-Va.), ...
... MOUNT PROSPECT, Ill., March 30 Introduced by ... in February 1999, the Verified Internet Pharmacy Practice ... patients. The VIPPS program enables consumers to confidently ... of legitimate Internet pharmacies in the nation. A ...
... March 30 VisionCare Ophthalmic Technologies, Inc., a ... with age-related macular degeneration (AMD), today announced the ... the FDA approve, with conditions, the premarket application ... The implantable telescope is the first medical device ...
... technique to distinguish benign moles from malignant melanomas ... Standard microscopic examinations of biopsied tissue can ... and supplementing standard practice with the new technique ... In a large study of previously diagnosed cases, ...
... A new study shows that people with multiple sclerosis may ... a higher risk of developing certain types of cancer, such ... in the March 31, 2009, print issue of Neurology ... , Researchers looked at the medical records of ...
Cached Medicine News:Health News:Takeda to Create Global Centers of Excellence 2Health News:Takeda to Create Global Centers of Excellence 3Health News:Takeda to Create Global Centers of Excellence 4Health News:AAOMS Applauds Legislation Enabling Medicare Patients to Rehabilitate and Recover More Efficiently From Oral and Maxillofacial Injuries 2Health News:VIPPS Celebrates 10th Anniversary, Continues to Guide Consumers to Legitimate Internet Pharmacies 2Health News:VIPPS Celebrates 10th Anniversary, Continues to Guide Consumers to Legitimate Internet Pharmacies 3Health News:FDA Advisory Panel Recommends Approval of VisionCare's Implantable Telescope for End-Stage Macular Degeneration 2Health News:FDA Advisory Panel Recommends Approval of VisionCare's Implantable Telescope for End-Stage Macular Degeneration 3Health News:New strategy developed to diagnose melanoma 2Health News:New strategy developed to diagnose melanoma 3Health News:Multiple sclerosis associated with lower cancer risk 2
(Date:5/16/2013)... NORTH CHICAGO, Ill. and MECHELEN, ... NV (Euronext: GLPG) and AbbVie (NYSE: ABBV ... development collaboration to include Crohn,s disease.  Galapagos will fund ... which is designed to facilitate rapid progression into Phase ... Q2 2015, AbbVie will pay Galapagos $50 million.  The ...
(Date:5/16/2013)... 2013  Today, the National Patient Advocate Foundation acknowledges ... of Representatives recently approved a bill that would prohibit ... higher out-of-pocket fees for newer, more expensive oral anti-cancer ... more severe side-effects. However, the bill was amended to ... continue to be a barrier to patients with cancer ...
(Date:5/16/2013)... , May 16, 2013  Amgen (NASDAQ: AMGN ... on Tuesday, May 21, 2013, at the Sheraton New York ... beginning at 10:00 a.m. Eastern Daylight Time. Joseph ... Research and Development at Amgen, will present at the conference. ... Events Calendar on Amgen,s website, www.amgen.com , under Investors. ...
Breaking Medicine Technology:AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3
... 2011 Healthpoint today announced the launch of a ... Biotherapeutics, along with an updated brandmark and corporate tagline, ... is designed to communicate the company,s commitment to scientific ... contribute to improved outcomes and quality of life for ...
... Md., Feb. 23, 2011 The Cystic Fibrosis Foundation and ... development that targets the defective protein that causes cystic fibrosis, ... The trial was designed to evaluate patients age ... a CF mutation called G551D. The study included 161 patients ...
Cached Medicine Technology:Healthpoint Launches New Corporate Identity 2Healthpoint Launches New Corporate Identity 3Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 2Phase 3 Study of VX-770 Shows Marked Improvement in Lung Function Among People with Cystic Fibrosis with G551D Mutation 3
... CCR Medical's Articulating Tip ... units in the Industry. The ... intubation by providing an improved ... Conventional and Fiber Optic styles. ...
German Style MacIntosh Fiber Optic Blade Laryngoscopes...
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
Medicine Products: